U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812571) titled 'Tenofovir Exposures in Advanced Kidney Disease Study' on Sept. 01.
Brief Summary: Phamacokinetic study to evaluate tenofovir, emtricitabine and tenofovir alafenamide exposures in people with HIV who have chronic kidney disease stage 4 (estimated glomerular filtration rate [eGFR] 15-29 mL/min/1.73m2) or stage 3 b (eGFR 30-44 mL/min/1.73m).
Study Start Date: Nov. 01
Study Type: OBSERVATIONAL
Condition:
Tenofovir
Tenofovir Alafenamide Fumarate
Chronic Kidney Diease
Kidney Failure
Pharmacokinetics
Intervention:
DIAGNOSTIC_TEST: Plasma sampling for tenofovir and emtricitabine
Samples will be used to measure tenofovir and emtricit...